Error: Could not add to watchlist. X

DSM Small Mid Cap Growth Fund

+ Watchlist
DSMMX:US
Liquidated
DSMMX:US was liquidated
USD
Fund Type
Open-End Fund
Fund Type
Open-End Fund
Objective
Growth Mid Cap
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on -)
-
Total Assets (m USD) (on 12/19/2014)
4.978
Inception Date
05/09/2013
Last Dividend (on 12/19/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
STEPHEN E MEMISHIAN "STEVE" / DANIEL B STRICKBERGER "DAN"
Front Load Fee
-
Back Load Fee
-
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.15%
Top Fund Holdings
Name Position Value % of Fund
Salix Pharmaceuticals Ltd 1.72 k 267.95 k 4.94
Pacira Pharmaceuticals Inc/DE 2.53 k 245.21 k 4.52
NPS Pharmaceuticals Inc 9.38 k 243.75 k 4.49
Affiliated Managers Group Inc 1.05 k 210.38 k 3.88
IPG Photonics Corp 2.74 k 188.46 k 3.48
YY Inc 2.44 k 183.11 k 3.38
EPAM Systems Inc 4.05 k 177.13 k 3.27
Ulta Salon Cosmetics & Fragran 1.48 k 174.30 k 3.21
Aegerion Pharmaceuticals Inc 5.15 k 171.74 k 3.17
Radware Ltd 9.50 k 167.77 k 3.09
Profile
DSM Small Mid Cap Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity securities of small and mid-sized capitalization companies.
ADDRESS
DSM Capital Partners LLC
116 Radio Circle Drive
Suite 200
Mount Kisco, NY 10549
PHONE
1-914-242-1900 Tel